with baseline ( 639 { 590 ) supraventricular ectopic hypertrophy on cardiac arrhythmias, 26 total was not initially reduced after blood hypertensive subjects were treated with ramipril pressure control ( 650 { 604 ) , but was reduced with felodipine if required, and followed for 6 after a further 6 months of treatment ( 294 { 261 ) . months after blood pressure control.
C
Both ventricular arrhythmias and sudden death are particularly common in hypertensive patients with left ventricular hypertrophy ( LVH ) as compared with those without. 3 -9 There are data suggesting that blood ompared with normotensives, patients with hypertension have a high risk of sudden death, 1 and this may be related to the increased prevalence of frequent and complex ventricular arrhythmias that have been observed. 2 pressure control with some drugs may reduce ventric-ular arrhythmias, 10 -15 but the mechanisms of this re-Spacelabs 90207 monitors. 16 Ambulatory monitoring was deemed acceptable if more than 90% of readings duction is unclear, and in particular there is little information on the effects of left ventricular regression were recorded. Mean blood pressure was calculated from the readings over the whole 24-h period. on these arrhythmias. Our hypothesis was that regression of left ventricular hypertrophy would lead to a Drug Therapy All patients entered a 4 week placebo significantly greater reduction in ventricular arrhythrun-in phase during which they made three visits to the mias than just blood pressure control. To test this we clinic. During this run-in phase each patient underwent assessed the impact of antihypertensive treatment baseline 2D echocardiography, Doppler ultrasound, 24-with ramipril, an angiotensin converting enzyme h ambulatory blood pressure studies, electrocardiogra-( ACE ) inhibitor and when required, the calcium anphy, exercise stress testing, venesection ( 5 mL ) for setagonist felodipine, on left ventricular ( LV ) mass and rum potassium concentration, 99m Tc-sestamibi ( MIBI ) ventricular arrhythmias. To attempt to unravel which scanning, and 24-h Holter monitoring. Baseline blood factors may be most important in determining any pressure was taken to be the value obtained at the third changes observed, we made measurements at basevisit just prior to commencement of antihypertensive line, after blood pressure control, 6 months after initial therapy. After the third visit patients were commenced blood pressure control ( after left ventricular regreson ramipril 5 mg once daily. If blood pressure remained sion ), and then after a further 3 week drug washout above the target value of 140 mm Hg systolic and 90 period.
mm Hg diastolic after 2 weeks, the dose was increased METHODS to 10 mg once daily. If after 2 weeks blood pressure remained above 140 mm Hg systolic and 90 mm Hg The study was approved by the St. Mary's Local Rediastolic, felodipine was added, initially at a dose of 5 search Ethics Committee and each subject gave writmg once daily and titrated up to 10 mg once daily if ten, informed consent.
necessary. Thereafter, if required, 2.5 mg of bendrofluPatients Twenty-three male and three female pa-azide was added. After blood pressure was controlled tients, all of whom had either a diastolic blood pressure each patient underwent repeat two-dimensional and of ú90 mm Hg or a systolic blood pressure of ú160 Doppler echocardiography, 24-h ambulatory blood mm Hg, were recruited from the Peart-Rose Clinic at pressure studies, venesection, and 24 h Holter monitorour institution. All subjects had a left ventricular mass ing. Thereafter patients' blood pressures were reviewed index ( LVMI ) of at least 110 g /m 2 for men and 100 g / monthly in the clinic. Tablet counts were performed at m 2 for women as assessed by two-dimensional ( 2D ) each visit to monitor compliance. After 6 months of echocardiography. Eighteen subjects were previously blood pressure control all prebaseline investigations exuntreated and 8 had hypertension that was uncon-cept MIBI scanning were repeated. Drug therapy was trolled on existing antihypertensive therapy. These then discontinued for 3 weeks, at which time all preeight patients underwent a 4 week washout period baseline investigations except 24-h blood pressure studwhen all antihypertensive therapy was stopped. All ies were again repeated. subjects had normal systolic function determined by Electrocardiography Standard 12-lead electrocardiotwo dimensional echocardiography and had no clinical grams ( ECG ) were recorded. Voltage height was meaor Doppler evidence of valvular stenosis or regurgitasured from SV 1 / RV 5 . Electrocardiographic strain was tion. Patients were excluded if they had a history of defined as ST depression or T-wave inversion in leads ischemic heart disease, peripheral vascular disease, V 5 and V 6 . All subjects also underwent treadmill exercongestive cardiac failure, diabetes mellitus, or alcohol cise testing using the Bruce protocol. 17 abuse, or became symptomatic with ST segment changes during exercise stress testing. White coat hy-Echocardiographic and Doppler Studies Each papertension was excluded using 24-h ambulatory blood tient underwent two-dimensional and Doppler echopressure monitoring ( no patient had an average 24-h cardiography using a phased array sector scanner diastolic blood pressure õ85 mm Hg ) and secondary ( General Electric Pass II, 3.3 MHz transducer ) using causes of hypertension were excluded by standard clin-a standardized examination protocol. 18 Interventricular ical investigation.
septal wall thickness ( IVS ) , posterior wall thickness ( PWT ), and left ventricular internal diameter ( LVID ) Blood Pressure The third of three seated blood pressures measured 2 min apart, using an automated moni-were measured from the left ventricular ( LV ) short axis view with 2D guided echocardiography. Measurements tor ( Sentron ) and a cuff of suitable size after the patient had been seated for 5 min, were recorded at each clinic were made at end-diastole in each of three separate frames in accordance with the Penn convention. 19 These visit. Twenty-four-hour ambulatory blood pressure measurements were made every 30 min through the diastolic measurements and all systolic measurements were also made using the leading edge to leading edge day ( 6 AM to 12 midnight ) and hourly at night using technique, as recommended by the American Society of Arrhythmias were also graded for complexity using the system described by Lown and Wolf. 24 Echocardiography. 20 Results of the three measurements for each structure were averaged. The results for IVS, Radionuclide Scanning Myocardial perfusion was LVID, and PWT presented are those measured using assessed in this study using MIBI scanning. Single phothe Penn convention. Left atrial size was measured us-ton emission computed tomography ( SPECT ) was used ing the American Society of Echocardiography guide-as the imaging modality due to its better resolution. lines. 20 Resting and exercise studies were performed 1 week Meridional wall stress and fractional shortening, an apart prior to which patients were asked to fast overindex of LV systolic function were derived from the night. For the study at rest 450 MBq of MIBI was inmeasurements made using the leading edge technique. jected intravenously and SPECT imaging with a gamma Meridional wall stress was calculated using a formula camera was carried out 1 h later. The exercise test was validated in humans 21 : meridional wall stress Å performed using a supine cycle. The patient was moni-0.334 ( SBP ) ( LVIDs)/PWTs(1 / PWTs / LVIDs ) dyne / tored electrocardiographically during the procedure cm 2 , where SBP Å systolic blood pressure, LVIDs Å and full resuscitation equipment was available. Blood left ventricular internal diameter in systole, and PWTs pressure was measured at baseline and after every stage Å posterior wall thickness in systole.
of the test, including at peak exercise. Work load was Fractional shortening of the LV was calculated from commenced at 25 watts and increased by a further 25 the following formula: fractional shortening Å ( LVID 0 watts every 3 min. At peak exercise the radioisotope LVIDs ) / LVID, where LVID Å left ventricular internal was injected intravenously; exercise was continued diameter in diastole and LVIDs Å left ventricular inter-thereafter for a further minute. Imaging was again carnal diameter in systole.
ried out 1 h later. LV mass was determined using an area 1 length
The MIBI scans were reported for the presence of method that has been validated in humans 22 : LV mass fixed and reversible defects by an experienced radiolo-
, where A1 and gist specializing in nuclear medicine. A2 represent the epicardial and endocardial areas, reStatistics All descriptive data is expressed as means spectively, measured by planimetry, and L1 and L2 repwith standard error of the mean ( SEM ) . Repeated mearesent the length of the LV from the mitral annulus to sures analysis of variance was used to assess the sigepicardial and endocardial borders, respectively. The nificance of longitudinal changes in measured vari-LVMI was determined by dividing LV mass by body ables. Bonferroni multiple comparison test was used to surface area.
compare individual points in time. For nonparametric Peak flow velocity E / A ratio and the isovolumic redata Friedman nonparametric repeated measures test laxation time ( IVRT ) were used as indices of left venwas used in conjunction with Dunn's multiple comparitricular diastolic function; these were measured as presons test. Paired Student's t tests were used to compare viously described. 23 measurements made on the same patient on two occaTwenty-four-hour Holter Monitoring Ambulatory sions. For categorical comparisons of prospective ECG recordings were made using Oxford Medilog changes McNemar's test was used. To see if any rela-4000-II recorders. Recordings were analyzed blindly for tionships existed between blood pressure reduction and total ventricular ectopic ( VE ) count and supraventricu-LVMI change simple regression analysis was performed. lar ectopic ( SVE ) count by an experienced technician. 
RESULTS
the measured parameters of LV diastolic or systolic function occurred throughout the study. The mean age of all subjects studied was 51 years Table 4 shows the frequency of cardiac arrhythmias ( range, 23 to 68 ) . Mean values for body mass index, as indicated by 24-h Holter monitoring at baseline and serum potassium, heart rate, and blood pressure lev-the three stages of follow up. The reduction in total els at baseline, at blood pressure control, after 6 24-h VE count at blood pressure control was not mainmonths of further blood pressure control, and after tained after 6 months of treatment, either before or the final 3 week washout period are shown in Table  after drug washout. The converse effect was observed 1. Mean baseline sitting blood pressure was 172 / 102.
on SVE count, although the large reductions observed Four patients achieved blood pressure control on ramafter prolonged blood pressure control and after ipril alone and 22 required the addition of felodipine.
washout were not statistically significant. Frequent Two needed the addition of bendrofluazide 2.5 mg to and complex ventricular arrhythmias ( Lown 2/ ) achieve blood pressure control. Blood pressure conwere reduced during blood pressure control, although trol was achieved after a mean period of 2.2 { 0.2 these changes also were not statistically significant. months from baseline. Mean follow-up period from
The majority of patients had ST segment changes blood pressure control was 6.3 { 0.2 months.
during exercise as shown in the results of exercise Table 2 shows baseline levels of, and changes in, stress testing ( Table 5 ) but no patient was also sympcardiac structure at the three stages of follow up. Electomatic ( an exclusion criterion for the study ) . Howtrocardiographic regression of LVH was apparent, ever no significant change in these or any of the other and echocardiographic interventricular septal thickvariables measured during stress testing ( except ness and LVMI, but not left atrial size, were signifiblood pressures ) were observed throughout the cantly reduced during follow-up. There was a signifistudy. cant relationship between the decrease in systolic At baseline, 13 of 25 ( the results of one patient were blood pressure ( mm Hg ) and the decrease in LVMI not interpretable ) had at least one small stress-induc-(g /m 2 ) observed between baseline and 6 months after ible perfusion defect ( 52% ) demonstrable with MIBI blood pressure control ( r Å 0.41, P Å .05 ) . Left ventricscanning. After drug washout the defect had reduced ular wall stress was decreased at blood pressure conin size in five patients, increased in seven, and retrol but increased towards baseline values after 6 mained the same in one. No patient developed a demonths. Table 3 shows that no significant changes in any of fect during the course of the study. There was no dif- ference in baseline LVMI, blood pressure, or VE total The Effects of Treatment on Ventricular Arrhythmias between the groups of patients with or without a per-The finding of no reduction in total VEs despite a sigfusion defect. nificant reduction in LV wall stress observed during follow-up ( except for a transient initial decrease at DISCUSSION blood pressure control ) was surprising because it conflicts with the findings of all previous studies.
TWENTY-FOUR-HOUR HOLTER RESULTS (ECTOPIC TOTAL AND LOWN SCORE) (MEAN { SEM)

The Effects of Treatment on LV Structure and Func-
The finding in a number of studies of a reduction in tion Compared with baseline LVMI was significantly the number of VEs in 24 h with short-term antihyperreduced after 6 months of blood pressure control to an tensive therapy ( typically 2 months or less ) using calextent similar to that reportedly induced by angiotensin cium antagonists, 10,12,13,15 b-blockers, 11,15 and ACE inconverting enzyme inhibitors. 25 The strong correlation hibitors, 14 but not thiazide diuretics, 12-15 is compatible coefficient between blood pressure reduction and LVMI with our findings. However, of the few studies asreduction observed in this study would suggest that sessing the impact of longer term treatment on LVH, hemodynamic effects probably are the most important one study of 6 months of therapy with the calcium ones causing this regression.
antagonist isradipine in 12 hypertensive patients with LV systolic function as assessed by the fractional LVH 30 found a reduction in the number and complexity shortening of the ventricle was normal at baseline.
of ventricular ectopics in conjunction with a reduction There was an 18% increase in fractional shortening bein LVH. A similar study investigated 27 hypertensive tween the beginning and very end of the study. This patients with LVH: 14 treated with an ACE inhibitor change was not statistically significant so little emphaand 13 with placebo 31 for 6 months. The ACE inhibitor sis can be placed on this result. In keeping with group had a reduction in the number and complexity some 26, 27 but not other 28, 29 studies, LVDF, as assessed of VEs again in association with a reduction in LVH, by mean peak flow velocity E / A ratio and IVRT, did whereas the placebo group had an increase in LVH not improve in spite of the reductions in blood pressure and LVMI.
with no change in the frequency or complexity of ar- / 2e19$$2205 05-07-97 12:01:56 eajha EL: AJH rhythmia. They noted that blood pressure reduction There were no differences pre-and post-treatment in either ventricular or SVE counts inducible by exercise. and regression of LVMI were both correlated to the reduction in arrhythmias. Preliminary results from anRadionuclide scanning using thallium-201 perfusion scans, which in normotensive patients has a very high other group investigating the effects of treatment with an ACE inhibitor or calcium antagonist on ventricular negative predictive value for coronary heart disease, are frequently positive in hypertensive patients with arrhythmias in hypertensives with and without LVH show a reduction in frequency and complexity of ar-normal coronary arteries, especially in the presence of significant LVH. [41] [42] [43] [44] Reversible defects may be due to rhythmia after 6 months. 32 However following drug washout, both frequency and complexity of arrhythmia epicardial coronary artery disease or depressed coronary flow reserve. 45 Scanning with MIBI as the radionuincreased in those patients with LVH. The hypertensives included in the first two studies differed from clide agent would be expected to have the same limitations as thallium in this group of patients. those in the present study in that they had very high levels of baseline arrhythmias. However, although hyWe wondered whether impaired myocardial perfusion as determined by reversible defects would be an pertensives in the third study 32 had a similar prevalence of VE at baseline to our study, we have not been important factor in determining which hypertensive patients would have ventricular arrhythmias and able to confirm their findings, particularly with regard to the effect of drug withdrawal. Interestingly, the find-whether changes in perfusion after antihypertensive treatment would effect these arrhythmias. However, ings of the present study are very similar to those of a recently reported animal study using spontaneously there was no difference in LVMI, blood pressure, or VE total between the groups of patients with or without hypertensive rats. 33 In that study the pattern of change in ventricular ectopic total in relation to ACE inhibitor-myocardial perfusion defects at baseline, nor were these defects affected by changes in LVMI or blood pressure. induced regression of left ventricular hypertrophy closely mirrored our results, with an initial reduction Thus radionuclide scanning does not identify patients at the highest risk of arrhythmia. Additionally there in number, followed by a later increase back to baseline levels.
was also no correlation between improvement or worsening of a defect with changes in VE total. Although the changes in VE total did not achieve statistical significance the pattern of change does de-The Effects of Treatment on Supraventricular Arserve some comment. The initial reduction in VE total rhythmias The total SVE count was similar at baseline is to a prevalence that is very similar to that of our and at the time of blood pressure control. However a ''normal'' population. 34 This initial reduction at blood large, although statistically nonsignificant, decrease in pressure control would be in keeping with the signifi-the SVE count was observed 6 months later and was cant reduction in LV wall stress, which may be an im-similar both pre-and post-drug washout. The lack of portant factor in determining ventricular arrhythmias. 35 statistical significance relates to the large variability of However, although the total VE count increased back this parameter, which, given the small study size, reto baseline levels by the end of the study, LV wall stress sulted in limited power to detect statistical significance. did not. If the reduction in LV wall stress did cause the However these SVEs may be important, as they may initial decrease in VE count, then some other factors herald the development of atrial fibrillation, which sigmust have induced VEs later in the study. Neither se-nificantly increases the risk of stroke.
46,47 Hypertension rum potassium concentration nor left ventricular inter-is associated with an increased left atrial size and nal diameter, both of which are associated with ventric-stretching of the atrial wall may precipitate atrial ectopular arrhythmias, 36, 37 changed through the study. The ics. However the reduction in SVE count was not associlack of change in VE total after drug washout seems to ated with a reduction in left atrial size. It is possible exclude a direct drug effect. There is animal evidence that left atrial pressure may have decreased without a that myocyte and collagen interstitial matrix may re-change in atrial size and this may be a more important gress differentially. 38 One possible explanation for our determinant of supraventricular arrhythmias. However findings is that antihypertensive therapy may lead to a there was no decrease when blood pressure was inigreater regression of myocyte mass than collagen inter-tially reduced, and hence a more sustained pressure stitial matrix, eventually leading to a LV with a greater decrease may be required in the atrium before its arrproportion of collagen matrix. This may be more ar-hythmogenecity is reduced. rhythmogenic and in the present study may have attenuated the effects of the reduction in LV wall stress by Limitations of the Study The study did not, for ethical reasons, include a control group who did not unthe end of the study.
Exercise stress testing has been used to assess cardiac dergo antihypertensive treatment. A further limitation of the study was the uncertainty of the influence of arrhythmias in patients in other settings. 39 
